CIRC Biosciences
- Employees
- 1–10
- Business Model
- B2B
- Website
- circbiosciences.com
- Total Funding
- $15.0M
- Last Round
- $15.0M Corporate RoundAug 2025
- Rounds
- 2
About
CiRC Biosciences is a regenerative medicine company developing cellular reprogramming therapies for degenerative eye and brain diseases.
Summary
CIRC Biosciences is a Biotech company. It has raised $15.0M in total across 2 rounds, most recently a $15.0M Corporate Round round in Aug 2025. Investors include Harmony Biosciences, Paragon Biosciences and Valor Equity Partners.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2025
Sign up to see all 2 rounds
Venture Round through Corporate Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/circ-biosciences"><img src="https://indexed.vc/api/badge/company/circ-biosciences" alt="CIRC Biosciences on Indexed.vc" width="260" height="76" /></a>